GW & Wade’s Idexx Laboratories IDXX Stock Holding History

GW & Wade’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$927K	Sell	1,670 -1	-0.1%	-$469	0.03%	232
2023 Q3	$731K	Buy	1,671 +32	+2%	+$16K	0.03%	243
2023 Q2	$823K	Buy	1,639 +6	+0.4%	+$2.88K	0.03%	228
2023 Q1	$817K	Sell	1,633 -102	-6%	-$48.8K	0.03%	218
2022 Q4	$708K	Sell	1,735 -175	-9%	-$67.9K	0.03%	224
2022 Q3	$622K	Buy	1,910 +186	+11%	+$68.3K	0.03%	218
2022 Q2	$605K	Buy	1,724 +168	+11%	+$68.5K	0.03%	232
2022 Q1	$851K	Buy	1,556 +24	+2%	+$12.6K	0.04%	197
2021 Q4	$1.01M	Buy	1,532 +171	+13%	+$107K	0.04%	190
2021 Q3	$846K	Buy	1,361 +15	+1%	+$10.1K	0.04%	199
2021 Q2	$850K	Sell	1,346 -510	-27%	-$282K	0.04%	197
2021 Q1	$908K	Buy	1,856 +721	+64%	+$361K	0.05%	169
2020 Q4	$567K	Buy	+1,135	New	+$508K	0.03%	182

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

GW & Wade's IDXX Position: Q4 2023 in Review

GW & Wade reduced its Idexx Laboratories (IDXX) stake by 0.06% in Q4 2023, selling an estimated $469 and leaving 1,670 shares worth $927K. The position accounts for 0.03% of the portfolio, ranked #232.

GW & Wade first reported a position in IDXX in Q4 2020 and has held it in 13 quarters since. The position peaked at $1.01M in Q4 2021. 1,154 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

GW & Wade held 1,670 shares of Idexx Laboratories worth $927K as of Q4 2023.
GW & Wade sold 1 Idexx Laboratories share in Q4 2023, an estimated $469.
Idexx Laboratories made up 0.03% of GW & Wade's portfolio in Q4 2023, its #232 holding.
GW & Wade first reported a position in Idexx Laboratories in Q4 2020 and has held it in 13 quarters since.
GW & Wade's Idexx Laboratories position peaked at $1.01M in Q4 2021.
1,154 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.